PillRx only · Tablet, Film Coated · Oral
Dasatinib
Dasatinib
8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US54 NDCs
8 active makers
8 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$26.413
Latest avg · Jul 22, 2026
-13%
Since Dec 17, 2025
8
Active US suppliers
33%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
1.5K
Rx · 2026 Q1
47K
Units dispensed
-28%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it8 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | unknown | 12 | SUPPLYING |
| AvKARE | unknown | 6 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | unknown | 6 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 6 | SUPPLYING |
| Apotex Corp. | unknown | 6 | SUPPLYING |
| BluePoint Laboratories | unknown | 6 | SUPPLYING |
| NorthStar RxLLC | unknown | 6 | SUPPLYING |
| Biocon Pharma Inc | unknown | 6 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.